For NU SKIN ENTERPRISES, the environment deterioration entails a downgrade to Neutral
NU SKIN ENTERPRISES (US), a company active in the Personal Products & Services industry, now shows a lower overall rating. The independent financial analyst theScreener just confirmed the fundamental rating of 3 stars out of 4, as well as the stock market behaviour of the title as moderately risky. However, environmental deterioration penalises the general evaluation, which is downgraded to Neutral. As of the analysis date November 30, 2021, the closing price was USD 43.88 and its expected value was estimated at USD 43.97.Nu Skin Enterprises develops and distributes a line of beauty and wellness solutions. The company's primary product categories are personal care products and wellness products. The company develops and distributes products in these two categories under its Nu Skin and Pharmanex brands, respectively. The company's personal care products include its skin care devices. The company's skin care devices and related consumables are ageLOC Spa systems and its ageLOC LumiSpa skin treatment and cleansing device. The company's wellness products line includes its LifePak nutritional supplements, ageLOC Youth nutritional supplements and its ageLOC TR90 weight management and body shaping system.
Empowering Investors
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
- Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
- theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
- For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.